Author:
Onchan Tippawan,Foocharoen Chingching,Pongkulkiat Patnarin,Suwannaroj Siraphop,Mahakkanukrauh Ajanee
Funder
The Thailand National Science, Research, and Innovation Fund
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Ashton, C., Paramalingam, S., Stevenson, B., Brusch, A. & Needham, M. Idiopathic inflammatory myopathies: A review. Intern. Med. J. 51(6), 845–852 (2021).
2. Hočevar, A. et al. Survival of patients with idiopathic inflammatory myopathies in Slovenia. Front. Med. 20(8), 801078 (2021).
3. Essouma, M., Noubiap, J. J., Singwe-Ngandeu, M. & Hachulla, E. Epidemiology of idiopathic inflammatory myopathies in Africa: A contemporary systematic review. J. Clin. Rheumatol. Pract. Rep. Rheum. Musculoskelet. Dis. 28(2), e552–e562 (2022).
4. Furst, D. E., Amato, A. A., Iorga, ŞR., Gajria, K. & Fernandes, A. W. Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan. Muscle Nerve. 45(5), 676–683 (2012).
5. Smoyer-Tomic, K. E., Amato, A. A. & Fernandes, A. W. Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: An administrative claims analysis. BMC Musculoskelet. Disord. 15(13), 103 (2012).